Dr Stearns on the Role of Carboplatin in Early-Stage TNBCByVered Stearns, MDDecember 6th 2024Vered Stearns, MD, discusses the role of carboplatin in early-stage triple-negative breast cancer according to results from the phase 3 PEARLY trial.
Dr Stearns on the Efficacy of Avelumab in TNBC ByVered Stearns, MDNovember 27th 2024Vered Stearns, MD, discusses the efficacy of avelumab as adjuvant therapy in patients with early triple-negative breast cancer.